论文部分内容阅读
目的观察阿奇霉素在临床上对成人感染支原体肺炎的治疗效果。方法 322例支原体肺炎患者随机分为阿奇霉素组(166例)和罗红霉素组(156例),两组的一般治疗及对症治疗方法相同,阿奇霉素组在一般治疗的基础上加用阿奇霉素,罗红霉素组加用罗红霉素,观察两组患者在临床疗效及副作用方面的差异。结果阿奇霉素组比罗红霉素组临床治疗效果好,比较差异有统计学意义(P<0.05)。阿奇霉素与罗红霉素比较胃肠道反应、局部疼痛、肝功能异常率明显低,比较差异有统计学意义(P<0.05)。结论阿奇霉素在临床治疗成人支原体肺炎效果好、副作用少,值得临床推广应用。
Objective To observe the therapeutic effect of azithromycin on mycoplasma pneumonia in adults. Methods 322 cases of mycoplasma pneumonia patients were randomly divided into azithromycin group (166 cases) and roxithromycin group (156 cases), the two groups of general treatment and symptomatic treatment of the same method, azithromycin group in the general treatment based on the addition of azithromycin, Erythromycin group with roxithromycin, observe the two groups of patients in the clinical efficacy and side effects differences. Results Azithromycin group than roxithromycin clinical treatment effect is good, the difference was statistically significant (P <0.05). Azithromycin and roxithromycin compared gastrointestinal reactions, local pain, liver dysfunction rate was significantly lower, the difference was statistically significant (P <0.05). Conclusion Azithromycin in the clinical treatment of adult mycoplasma pneumonia is effective, less side effects, it is worth clinical application.